Neuronetics Reports First Quarter 2025 Financial and Operating Results

About this update from Neuronetics, Inc.

[{"type":"image","alt":"Neuronetics","displaySize":"","headline":null,"caption":"Neuronetics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":74,"url":"https://media.zenfs.com/en/globenewswire.com/c9ec2695435007e9fe00ba41ba1a5be2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/scHOldrogkGah0UUhyJ.bA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c9ec2695435007e9fe00ba41ba1a5be2","width":300,"height":74}},"lazy":false},{"type":"text","content":"MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating results for the first quarter of 2025.","length":439,"tagName":"p"},{"type":"text","content":"First Quarter 2025 Highlights ","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"First quarter 2025 revenue of $32.0 million, an 84% increase as compared to the first quarter 2024, primarily driven by the Greenbrook acquisition","length":146,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. clinic revenue of $18.7 million in the quarter representing Greenbrook clinic revenue","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. treatment session revenue of $9.6 million","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. NeuroStar Advanced Therapy System revenue of $2.8 million ","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed secondary offering, raising approximately $18.9 million in net proceeds in February 2025 after deducting underwriting discounts, commissions and estimated offering expenses","length":182,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":526,"olType":false},{"type":"text","content":"Recent Operational Highlights ","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Chief Financial Officer Steve Furlong to retire in March 2026","length":61,"tagName":"p"}]},{"val":[{"type":"text","content":"Significant operational progress with the integration of Greenbrook","length":67,"tagName":"...

More updates from Neuronetics, Inc.